Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Raises Capital for Growth with Existing Stockholder
25 nov. 2022 16h50 HE | Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 25, 2022 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Announces Completion of Corporate Name Change
14 nov. 2022 09h02 HE | Lifecore Biomedical, Inc.
Common stock expected to begin trading tomorrow under new Nasdaq ticker symbol “LFCR” Lifecore global headquarters relocated to Chaska, MN Launches new investor relations website: ir.lifecore.com ...
Landec_Logotype_CMYK - Logo 10-31-11.jpg
Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022
10 nov. 2022 08h00 HE | Landec Corporation
CHASKA, Minn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”), a diversified health and wellness company with two operating businesses, Lifecore...
Landec_Logotype_CMYK - Logo 10-31-11.jpg
Landec Expects to Change Corporate Name to Lifecore Biomedical and Ticker Symbol to “LFCR” on November 14
01 nov. 2022 08h00 HE | Landec Corporation
CHASKA, Minn., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Lifecore” or the “Company”) today announced that it expects to effect its previously announced corporate name...
Landec_Logotype_CMYK - Logo 10-31-11.jpg
Landec Corporation Reports First Quarter Fiscal Year 2023 Results
06 oct. 2022 07h15 HE | Landec Corporation
Lifecore segment revenues increased 8.0% to $23.7 million in fiscal 2023 first quarter versus the prior year periodLifecore segment EBITDA increased 8.1% to $2.5 million in fiscal 2023 first quarter...
Landec_Logotype_CMYK - Logo 10-31-11.jpg
Landec Corporation Revises First Quarter 2023 Earnings Conference Call for October 6, 2022 at 8:00 a.m. ET
28 sept. 2022 16h05 HE | Landec Corporation
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its...
Landec_Logotype_CMYK - Logo 10-31-11.jpg
Landec Corporation Sets First Quarter 2023 Earnings Conference Call for October 5, 2022 at 2:00 p.m. PT
21 sept. 2022 08h00 HE | Landec Corporation
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its...
Landec_Logotype_CMYK - Logo 10-31-11.jpg
Landec Corp. Receives Notice from Nasdaq Regarding Delayed Annual Report
09 sept. 2022 16h30 HE | Landec Corporation
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Landec Corp. (NASDAQ: LNDC) (the “Company”) announced today that it received a notice (“Notice”) on September 2, 2022 from the...
Landec_Logotype_CMYK - Logo 10-31-11.jpg
Landec Corporation Reports Fourth Quarter and Full Fiscal Year 2022 Results
10 août 2022 16h07 HE | Landec Corporation
Recently announced intent to rename and rebrand to Lifecore Biomedical, along with leadership and Board changes Lifecore segment revenues increased 6.9% to $27.6 million in fiscal fourth quarter,...
Landec_Logotype_CMYK - Logo 10-31-11.jpg
Landec Corporation Announces Intention to Become Lifecore Biomedical
10 août 2022 16h04 HE | Landec Corporation
Landec expected to rename and rebrand to Lifecore Biomedical and update Nasdaq ticker symbol Names new CEO Announces future changes to its Board of Directors SANTA MARIA, Calif. and MINNEAPOLIS,...